OVA-K4 Peptide, SIIKFEKL, OVA (257-264) Variant contains a lysine at position 4 to test anchor replacement effects within the OVA epitope. Its sequence supports assessments of peptide–MHC geometry and stability. Researchers employ it to analyze T-cell responses to modified antigen surfaces. The peptide aids structure–function comparison with native SIINFEKL.
CAT No: O05020
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More